{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,8]],"date-time":"2026-11-08T10:33:29Z","timestamp":1794134009115,"version":"4.8.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,11,6]],"date-time":"2023-11-06T00:00:00Z","timestamp":1699228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,11,6]],"date-time":"2023-11-06T00:00:00Z","timestamp":1699228800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Med Res"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Irritable bowel syndrome (IBS) is a prevalent gastrointestinal (GI) tract disorder. Although the main reason for IBS is not clear, the interaction between intestinal microorganisms and the gut barrier seems to play an important role in pathogenesis of IBS. The current study aimed to investigate the effect of <jats:italic>Blastocystis<\/jats:italic> on the gut microbiota profile and the circulation levels of microRNA (mir)-16 of IBS patients compared to healthy subjects. Stool and blood samples were collected from 80 participants including 40 samples from each IBS and healthy group. Upon DNA extraction from stool samples, barcoding region and quantitative real-time PCR were analyzed to investigate <jats:italic>Blastocystis<\/jats:italic> and the microbiota profile, respectively. RNA was extracted from serum samples of included subjects and the expression of mir-16 was evaluated using stem-loop protocol and qreal-time PCR. Significant changes between IBS patients and healthy controls was observed in Firmicutes<jats:italic>,<\/jats:italic> Actinobacteria<jats:italic>, Faecalibacterium,<\/jats:italic> and <jats:italic>Alistipes<\/jats:italic>. In IBS patients, the relative abundance of <jats:italic>Bifidobacteria<\/jats:italic> was directly correlated with the presence of <jats:italic>Blastocystis<\/jats:italic>, while <jats:italic>Alistipes<\/jats:italic> was decreased with <jats:italic>Blastocystis<\/jats:italic>. <jats:italic>Lactobacillus<\/jats:italic> was significantly increased in <jats:italic>Blastocystis<\/jats:italic> carriers. In healthy subjects, the relative abundance of <jats:italic>Bifidobacteria<\/jats:italic> was decreased, but <jats:italic>Alistipes<\/jats:italic> was increased in <jats:italic>Blastocystis<\/jats:italic> carriers. The changes in the Firmicutes\/Bacteroidetes ratio was not significant in different groups. The relative expression of mir-16 in <jats:italic>Blastocystis<\/jats:italic>-negative IBS patients and healthy carriers was significantly overexpressed compared to control group. The presence of <jats:italic>Blastocystis<\/jats:italic>, decreased the relative expression of mir-16 in IBS patients compared to <jats:italic>Blastocystis<\/jats:italic>-negative IBS patients. The present study revealed that <jats:italic>Blastocystis<\/jats:italic> has the ability to\u00a0change the abundance of some phyla\/genera of bacteria in IBS and healthy subjects. Moreover, <jats:italic>Blastocystis <\/jats:italic>seems to\u00a0 modulate the relative expression of microRNAs\u00a0 to\u00a0control the gut atmosphere, apply its pathogenicity, and provide a favor niche for its colonization.<\/jats:p>","DOI":"10.1186\/s40001-023-01441-8","type":"journal-article","created":{"date-parts":[[2023,11,6]],"date-time":"2023-11-06T08:01:53Z","timestamp":1699257713000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Profiling of the fecal microbiota and circulating microRNA-16 in IBS subjects with Blastocystis infection\u00a0: a case\u2013control study"],"prefix":"10.1186","volume":"28","author":[{"given":"Alireza","family":"Olyaiee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abbas","family":"Yadegar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elnaz Sadat","family":"Mirsamadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir","family":"Sadeghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamed","family":"Mirjalali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,11,6]]},"reference":[{"key":"1441_CR1","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.890127","volume":"9","author":"A Olyaiee","year":"2022","unstructured":"Olyaiee A, Sadeghi A, Yadegar A, Mirsamadi ES, Mirjalali H. Gut microbiota shifting in irritable bowel syndrome: the mysterious role of Blastocystis sp. Front Med (Lausanne). 2022;9: 890127.","journal-title":"Front Med (Lausanne)"},{"key":"1441_CR2","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/s12876-021-01693-w","volume":"21","author":"L Mei","year":"2021","unstructured":"Mei L, Zhou J, Su Y, Mao K, Wu J, Zhu C, He L, Cui Y. Gut microbiota composition and functional prediction in diarrhea-predominant irritable bowel syndrome. BMC Gastroenterol. 2021;21:105.","journal-title":"BMC Gastroenterol"},{"key":"1441_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2019.11.023","volume":"51","author":"PH Johnsen","year":"2020","unstructured":"Johnsen PH, Hilp\u00fcsch F, Valle PC, Goll R. The effect of fecal microbiota transplantation on IBS related quality of life and fatigue in moderate to severe non-constipated irritable bowel: Secondary endpoints of a double blind, randomized, placebo-controlled trial. EBioMedicine. 2020;51: 102562.","journal-title":"EBioMedicine"},{"key":"1441_CR4","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s40168-016-0191-0","volume":"4","author":"R Nagel","year":"2016","unstructured":"Nagel R, Traub RJ, Allcock RJ, Kwan MM, Bielefeldt-Ohmann H. Comparison of faecal microbiota in Blastocystis-positive and Blastocystis-negative irritable bowel syndrome patients. Microbiome. 2016;4:47.","journal-title":"Microbiome"},{"key":"1441_CR5","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.3906\/sag-2002-57","volume":"50","author":"HF Dale","year":"2020","unstructured":"Dale HF, Lied GA. Gut microbiota and therapeutic approaches for dysbiosis in irritable bowel syndrome: recent developments and future perspectives. Turk J Med Sci. 2020;50:1632\u201341.","journal-title":"Turk J Med Sci"},{"key":"1441_CR6","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1172\/JCI130976","volume":"130","author":"L Zhao","year":"2020","unstructured":"Zhao L, Yang W, Chen Y, Huang F, Lu L, Lin C, Huang T, Ning Z, Zhai L, Zhong LL, et al. A Clostridia-rich microbiota enhances bile acid excretion in diarrhea-predominant irritable bowel syndrome. J Clin Invest. 2020;130:438\u201350.","journal-title":"J Clin Invest"},{"issue":"Suppl 1","key":"1441_CR7","first-page":"111","volume":"12","author":"A Gasbarrini","year":"2008","unstructured":"Gasbarrini A, Lauritano EC, Garcovich M, Sparano L, Gasbarrini G. New insights into the pathophysiology of IBS: intestinal microflora, gas production and gut motility. Eur Rev Med Pharmacol Sci. 2008;12(Suppl 1):111\u20137.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"1441_CR8","doi-asserted-by":"publisher","first-page":"1792","DOI":"10.1053\/j.gastro.2011.07.043","volume":"141","author":"M Rajili\u0107-Stojanovi\u0107","year":"2011","unstructured":"Rajili\u0107-Stojanovi\u0107 M, Biagi E, Heilig HG, Kajander K, Kekkonen RA, Tims S, de Vos WM. Global and deep molecular analysis of microbiota signatures in fecal samples from patients with irritable bowel syndrome. Gastroenterology. 2011;141:1792\u2013801.","journal-title":"Gastroenterology"},{"key":"1441_CR9","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/s40168-015-0139-9","volume":"3","author":"V Shankar","year":"2015","unstructured":"Shankar V, Reo NV, Paliy O. Simultaneous fecal microbial and metabolite profiling enables accurate classification of pediatric irritable bowel syndrome. Microbiome. 2015;3:73.","journal-title":"Microbiome"},{"key":"1441_CR10","doi-asserted-by":"publisher","first-page":"1808","DOI":"10.3390\/jcm8111808","volume":"8","author":"S Fagoonee","year":"2019","unstructured":"Fagoonee S, Pellicano R. Does the microbiota play a pivotal role in the pathogenesis of irritable bowel syndrome? J Clin Med. 2019;8:1808.","journal-title":"J Clin Med"},{"key":"1441_CR11","doi-asserted-by":"publisher","first-page":"e00007","DOI":"10.1128\/mSystems.00007-18","volume":"3","author":"M Nieves-Ram\u00edrez","year":"2018","unstructured":"Nieves-Ram\u00edrez M, Partida-Rodr\u00edguez O, Laforest-Lapointe I, Reynolds L, Brown E, Valdez-Salazar A, Mor\u00e1n-Silva P, Rojas-Vel\u00e1zquez L, Morien E, Parfrey L. Asymptomatic intestinal colonization with protist Blastocystis is strongly associated with distinct microbiome ecological patterns. Msystems. 2018;3:e00007-00018.","journal-title":"Msystems"},{"key":"1441_CR12","doi-asserted-by":"publisher","first-page":"687","DOI":"10.2166\/wh.2021.011","volume":"19","author":"S Nemati","year":"2021","unstructured":"Nemati S, Zali MR, Johnson P, Mirjalali H, Karanis P. Molecular prevalence and subtype distribution of Blastocystis sp. in Asia and in Australia. J Water Health. 2021;19:687\u2013704.","journal-title":"J Water Health"},{"key":"1441_CR13","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.mehy.2018.04.006","volume":"116","author":"S Cifre","year":"2018","unstructured":"Cifre S, Gozalbo M, Ortiz V, Soriano JM, Merino JF, Trelis M. Blastocystis subtypes and their association with Irritable Bowel Syndrome. Med Hypotheses. 2018;116:4\u20139.","journal-title":"Med Hypotheses"},{"key":"1441_CR14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0015484","volume":"5","author":"F Dogruman-Al","year":"2010","unstructured":"Dogruman-Al F, Simsek Z, Boorom K, Ekici E, Sahin M, Tuncer C, Kustimur S, Altinbas A. Comparison of methods for detection of Blastocystis infection in routinely submitted stool samples, and also in IBS\/IBD Patients in Ankara. Turkey PLoS One. 2010;5: e15484.","journal-title":"Turkey PLoS One"},{"key":"1441_CR15","doi-asserted-by":"publisher","first-page":"2848","DOI":"10.1038\/ismej.2017.139","volume":"11","author":"F Beghini","year":"2017","unstructured":"Beghini F, Pasolli E, Truong TD, Putignani L, Cacci\u00f2 SM, Segata N. Large-scale comparative metagenomics of Blastocystis, a common member of the human gut microbiome. ISME J. 2017;11:2848\u201363.","journal-title":"ISME J"},{"key":"1441_CR16","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/s41591-020-01183-8","volume":"27","author":"F Asnicar","year":"2021","unstructured":"Asnicar F, Berry SE, Valdes AM, Nguyen LH, Piccinno G, Drew DA, Leeming E, Gibson R, Le Roy C, Khatib HA. Microbiome connections with host metabolism and habitual diet from 1,098 deeply phenotyped individuals. Nat Med. 2021;27:321\u201332.","journal-title":"Nat Med"},{"key":"1441_CR17","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1186\/s12866-021-02341-9","volume":"21","author":"SA Karamati","year":"2021","unstructured":"Karamati SA, Mirjalali H, Niyyati M, Yadegar A, Asadzadeh Aghdaei H, Haghighi A, Seyyed Tabaei SJ. Association of Blastocystis ST6 with higher protease activity among symptomatic subjects. BMC Microbiol. 2021;21:285.","journal-title":"BMC Microbiol"},{"key":"1441_CR18","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1111\/j.1462-5822.2012.01814.x","volume":"14","author":"H Mirza","year":"2012","unstructured":"Mirza H, Wu Z, Teo JD, Tan KS. Statin pleiotropy prevents rho kinase-mediated intestinal epithelial barrier compromise induced by Blastocystis cysteine proteases. Cell Microbiol. 2012;14:1474\u201384.","journal-title":"Cell Microbiol"},{"key":"1441_CR19","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/s12866-022-02528-8","volume":"22","author":"H Mohammad Rahimi","year":"2022","unstructured":"Mohammad Rahimi H, Yadegar A, Asadzadeh Aghdaei H, Mirjalali H, Zali MR. Modulation of microRNAs and claudin-7 in Caco-2 cell line treated with Blastocystis sp., subtype 3 soluble total antigen. BMC Microbiol. 2022;22:111.","journal-title":"BMC Microbiol"},{"key":"1441_CR20","doi-asserted-by":"publisher","unstructured":"Chatterjee B, Sarkar M, Bose S, Alam MT, Chaudhary AA, Dixit AK, Tripathi PP, Srivastava AK: MicroRNAs: Key modulators of inflammation-associated diseases. In: Seminars in Cell & Developmental Biology. Elsevier; 2023. https:\/\/doi.org\/10.1016\/j.semcdb.2023.01.009","DOI":"10.1016\/j.semcdb.2023.01.009"},{"key":"1441_CR21","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1136\/gutjnl-2016-311477","volume":"66","author":"C Mart\u00ednez","year":"2017","unstructured":"Mart\u00ednez C, Rodi\u00f1o-Janeiro BK, Lobo B, Stanifer ML, Klaus B, Granzow M, Gonz\u00e1lez-Castro AM, Salvo-Romero E, Alonso-Cotoner C, Pigrau M. miR-16 and miR-125b are involved in barrier function dysregulation through the modulation of claudin-2 and cingulin expression in the jejunum in IBS with diarrhoea. Gut. 2017;66:1537\u20138.","journal-title":"Gut"},{"key":"1441_CR22","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.940332","volume":"9","author":"M Norouzi","year":"2022","unstructured":"Norouzi M, Pirestani M, Arefian E, Dalimi A, Sadraei J, Mirjalali H. Exosomes secreted by Blastocystis subtypes affect the expression of proinflammatory and anti-inflammatory cytokines (TNF\u03b1, IL-6, IL-10, IL-4). Front Med (Lausanne). 2022;9: 940332.","journal-title":"Front Med (Lausanne)"},{"key":"1441_CR23","doi-asserted-by":"publisher","first-page":"499","DOI":"10.3389\/fmicb.2023.1147945","volume":"14","author":"FS Gholam-Mostafaei","year":"2023","unstructured":"Gholam-Mostafaei FS, Azimirad M, Naseri K, Nabavi-Rad A, Asadzadeh Aghdaei H, Shahrokh S, Ebrahimi Daryani N, Yadegar A, Zali MR. Intestinal microbiota changes pre-and post-fecal microbiota transplantation for treatment of recurrent Clostridioides difficile infection among Iranian patients with concurrent inflammatory bowel disease. Front Microbiol. 2023;14:499.","journal-title":"Front Microbiol"},{"key":"1441_CR24","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.mimet.2011.06.010","volume":"86","author":"TB De Gregoris","year":"2011","unstructured":"De Gregoris TB, Aldred N, Clare AS, Burgess JG. Improvement of phylum-and class-specific primers for real-time PCR quantification of bacterial taxa. J Microbiol Method. 2011;86:351\u20136.","journal-title":"J Microbiol Method"},{"key":"1441_CR25","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.3390\/nu12041096","volume":"12","author":"M Moszak","year":"2020","unstructured":"Moszak M, Szuli\u0144ska M, Bogda\u0144ski P. You are what you eat\u2014the relationship between diet, microbiota, and metabolic disorders\u2014a review. Nutrients. 2020;12:1096.","journal-title":"Nutrients"},{"key":"1441_CR26","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1042\/BCJ20160510","volume":"474","author":"E Thursby","year":"2017","unstructured":"Thursby E, Juge N. Introduction fo the human gut flora. Biochem J. 2017;474:1823\u201336.","journal-title":"Biochem J"},{"key":"1441_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2164-14-788","volume":"14","author":"ML Hermann-Bank","year":"2013","unstructured":"Hermann-Bank ML, Skovgaard K, Stockmarr A, Larsen N, M\u00f8lbak L. The gut microbiotassay: a high-throughput qPCR approach combinable with next generation sequencing to study gut microbial diversity. BMC Genomic. 2013;14:1\u201314.","journal-title":"BMC Genomic"},{"issue":"u209153","key":"1441_CR28","volume":"4","author":"N Springham","year":"2015","unstructured":"Springham N, Robert G. Experience based co-design reduces formal complaints on an acute mental health ward. BMJ Open Qual. 2015;4(u209153): w203970.","journal-title":"BMJ Open Qual"},{"key":"1441_CR29","doi-asserted-by":"publisher","first-page":"e00484","DOI":"10.1128\/Spectrum.00484-21","volume":"9","author":"S Keshavarz Azizi Raftar","year":"2021","unstructured":"Keshavarz Azizi Raftar S, Ashrafian F, Yadegar A, Lari A, Moradi HR, Shahriary A, Azimirad M, Alavifard H, Mohsenifar Z, Davari M. The protective effects of live and pasteurized Akkermansia muciniphila and its extracellular vesicles against HFD\/CCl4-induced liver injury. Microbiol Spect. 2021;9:e00484-e1421.","journal-title":"Microbiol Spect"},{"key":"1441_CR30","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1128\/AEM.05605-11","volume":"78","author":"I-K Wang","year":"2012","unstructured":"Wang I-K, Lai H-C, Yu C-J, Liang C-C, Chang C-T, Kuo H-L, Yang Y-F, Lin C-C, Lin H-H, Liu Y-L. Real-time PCR analysis of the intestinal microbiotas in peritoneal dialysis patients. Appl Environ Microbiol. 2012;78:1107\u201312.","journal-title":"Appl Environ Microbiol"},{"key":"1441_CR31","first-page":"560","volume":"9","author":"EM Quigley","year":"2013","unstructured":"Quigley EM. Gut bacteria in health and disease. Gastroenterol Hepatol. 2013;9:560.","journal-title":"Gastroenterol Hepatol"},{"key":"1441_CR32","doi-asserted-by":"publisher","first-page":"287","DOI":"10.3920\/BM2012.0018","volume":"3","author":"LK Vigsn\u00e6s","year":"2012","unstructured":"Vigsn\u00e6s LK, Brynskov J, Steenholdt C, Wilcks A, Licht TR. Gram-negative bacteria account for main differences between faecal microbiota from patients with ulcerative colitis and healthy controls. Beneficial Microb. 2012;3:287\u201397.","journal-title":"Beneficial Microb"},{"key":"1441_CR33","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1053\/j.gastro.2016.09.049","volume":"152","author":"J Tap","year":"2017","unstructured":"Tap J, Derrien M, T\u00f6rnblom H, Brazeilles R, Cools-Portier S, Dor\u00e9 J, St\u00f6rsrud S, Le Nev\u00e9 B, \u00d6hman L, Simr\u00e9n M. Identification of an intestinal microbiota signature associated with severity of irritable bowel syndrome. Gastroenterology. 2017;152:111-123.e118.","journal-title":"Gastroenterology"},{"key":"1441_CR34","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.3389\/fmicb.2018.01600","volume":"9","author":"X Zhuang","year":"2018","unstructured":"Zhuang X, Tian Z, Li L, Zeng Z, Chen M, Xiong L. Fecal microbiota alterations associated with diarrhea-predominant irritable bowel syndrome. Front Microbiol. 2018;9:1600.","journal-title":"Front Microbiol"},{"key":"1441_CR35","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1009253","volume":"17","author":"L Deng","year":"2021","unstructured":"Deng L, Wojciech L, Gascoigne NR, Peng G, Tan KS. New insights into the interactions between Blastocystis, the gut microbiota, and host immunity. PLoS Pathog. 2021;17: e1009253.","journal-title":"PLoS Pathog"},{"key":"1441_CR36","doi-asserted-by":"publisher","first-page":"34","DOI":"10.3390\/microorganisms10010034","volume":"10","author":"MJ Kim","year":"2021","unstructured":"Kim MJ, Lee YJ, Kim TJ, Won EJ. Gut microbiome profiles in colonizations with the enteric protozoa Blastocystis in Korean populations. Microorganisms. 2021;10:34.","journal-title":"Microorganisms"},{"key":"1441_CR37","doi-asserted-by":"publisher","first-page":"326","DOI":"10.3390\/microorganisms10020326","volume":"10","author":"CR Stensvold","year":"2022","unstructured":"Stensvold CR, S\u00f8rland BA, Berg R, Andersen LO, van der Giezen M, Bowtell JL, El-Badry AA, Belkessa S, Kurt \u00d6, Nielsen HV. Stool microbiota diversity analysis of Blastocystis-positive and Blastocystis-negative individuals. Microorganisms. 2022;10:326.","journal-title":"Microorganisms"},{"key":"1441_CR38","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1007\/s00436-012-2830-0","volume":"111","author":"A Olivo-Diaz","year":"2012","unstructured":"Olivo-Diaz A, Romero-Valdovinos M, Gudino-Ramirez A, Reyes-Gordillo J, Jimenez-Gonzalez DE, Ramirez-Miranda ME, Martinez-Flores WA, Martinez-Hernandez F, Flisser A, Maravilla P. Findings related to IL-8 and IL-10 gene polymorphisms in a Mexican patient population with irritable bowel syndrome infected with Blastocystis. Parasitol Res. 2012;111:487\u201391.","journal-title":"Parasitol Res"},{"key":"1441_CR39","first-page":"77","volume":"68","author":"MH Ismail","year":"2022","unstructured":"Ismail MH, Molan AL, Abbas SK. Serological levels of cytokines in irritable bowel syndrome (IBS) patients and non-IBS subjects with and without Blastocystis spp. infection. Ann Parasitol. 2022;68:77\u201385.","journal-title":"Ann Parasitol"},{"key":"1441_CR40","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1186\/s13071-015-1069-x","volume":"8","author":"R Nagel","year":"2015","unstructured":"Nagel R, Traub RJ, Kwan MM, Bielefeldt-Ohmann H. Blastocystis specific serum immunoglobulin in patients with irritable bowel syndrome (IBS) versus healthy controls. Parasit Vectors. 2015;8:453.","journal-title":"Parasit Vectors"},{"key":"1441_CR41","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/s12967-023-03953-7","volume":"21","author":"H Chen","year":"2023","unstructured":"Chen H, Ou R, Tang N, Su W, Yang R, Yu X, Zhang G, Jiao J, Zhou X. Alternation of the gut microbiota in irritable bowel syndrome: an integrated analysis based on multicenter amplicon sequencing data. J Transl Med. 2023;21:117.","journal-title":"J Transl Med"},{"key":"1441_CR42","doi-asserted-by":"publisher","first-page":"253","DOI":"10.5009\/gnl19379","volume":"15","author":"SM Lee","year":"2021","unstructured":"Lee SM, Kim N, Yoon H, Kim YS, Choi SI, Park JH, Lee DH. Compositional and functional changes in the gut microbiota in irritable bowel syndrome patients. Gut Liver. 2021;15:253\u201361.","journal-title":"Gut Liver"},{"key":"1441_CR43","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1159\/000477205","volume":"36","author":"LR Lopetuso","year":"2018","unstructured":"Lopetuso LR, Petito V, Graziani C, Schiavoni E, Paroni Sterbini F, Poscia A, Gaetani E, Franceschi F, Cammarota G, Sanguinetti M, et al. Gut microbiota in health, diverticular disease, irritable bowel syndrome, and inflammatory bowel diseases: time for microbial marker of gastrointestinal disorders. Dig Dis. 2018;36:56\u201365.","journal-title":"Dig Dis"},{"key":"1441_CR44","doi-asserted-by":"publisher","first-page":"35","DOI":"10.3390\/jpm11010035","volume":"11","author":"ZA Barandouzi","year":"2021","unstructured":"Barandouzi ZA, Lee J, Maas K, Starkweather AR, Cong XS. Altered gut microbiota in irritable bowel syndrome and its association with food components. J Pers Med. 2021;11:35.","journal-title":"J Pers Med"},{"key":"1441_CR45","doi-asserted-by":"publisher","first-page":"G799","DOI":"10.1152\/ajpgi.00154.2011","volume":"301","author":"IM Carroll","year":"2011","unstructured":"Carroll IM, Ringel-Kulka T, Keku TO, Chang YH, Packey CD, Sartor RB, Ringel Y. Molecular analysis of the luminal- and mucosal-associated intestinal microbiota in diarrhea-predominant irritable bowel syndrome. Am J Physiol Gastrointest Liver Physiol. 2011;301:G799-807.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"1441_CR46","doi-asserted-by":"publisher","first-page":"906","DOI":"10.3389\/fimmu.2020.00906","volume":"11","author":"BJ Parker","year":"2020","unstructured":"Parker BJ, Wearsch PA, Veloo ACM, Rodriguez-Palacios A. The genus alistipes: gut bacteria with emerging implications to inflammation, cancer, and mental health. Front Immunol. 2020;11:906.","journal-title":"Front Immunol"},{"key":"1441_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.mce.2022.111572","volume":"546","author":"KJ O'Riordan","year":"2022","unstructured":"O\u2019Riordan KJ, Collins MK, Moloney GM, Knox EG, Aburto MR, F\u00fclling C, Morley SJ, Clarke G, Schellekens H, Cryan JF. Short chain fatty acids: microbial metabolites for gut-brain axis signalling. Mol Cell Endocrinol. 2022;546: 111572.","journal-title":"Mol Cell Endocrinol"},{"key":"1441_CR48","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/s40168-019-0704-8","volume":"7","author":"K Oliphant","year":"2019","unstructured":"Oliphant K, Allen-Vercoe E. Macronutrient metabolism by the human gut microbiome: major fermentation by-products and their impact on host health. Microbiome. 2019;7:91.","journal-title":"Microbiome"},{"key":"1441_CR49","doi-asserted-by":"publisher","first-page":"540","DOI":"10.5056\/jnm22093","volume":"28","author":"W Jiang","year":"2022","unstructured":"Jiang W, Wu J, Zhu S, Xin L, Yu C, Shen Z. The role of short chain fatty acids in irritable bowel syndrome. J Neurogastroenterol Motil. 2022;28:540\u20138.","journal-title":"J Neurogastroenterol Motil"},{"key":"1441_CR50","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000014513","volume":"98","author":"Q Sun","year":"2019","unstructured":"Sun Q, Jia Q, Song L, Duan L. Alterations in fecal short-chain fatty acids in patients with irritable bowel syndrome: A systematic review and meta-analysis. Medicine (Baltimore). 2019;98: e14513.","journal-title":"Medicine (Baltimore)"},{"key":"1441_CR51","doi-asserted-by":"publisher","first-page":"3201","DOI":"10.1111\/1462-2920.14271","volume":"20","author":"G Gargari","year":"2018","unstructured":"Gargari G, Taverniti V, Gardana C, Cremon C, Canducci F, Pagano I, Barbaro MR, Bellacosa L, Castellazzi AM, Valsecchi C, et al. Fecal clostridiales distribution and short-chain fatty acids reflect bowel habits in irritable bowel syndrome. Environ Microbiol. 2018;20:3201\u201313.","journal-title":"Environ Microbiol"},{"key":"1441_CR52","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1038\/s41575-019-0157-3","volume":"16","author":"B Dalile","year":"2019","unstructured":"Dalile B, Van Oudenhove L, Vervliet B, Verbeke K. The role of short-chain fatty acids in microbiota-gut-brain communication. Nat Rev Gastroenterol Hepatol. 2019;16:461\u201378.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"1441_CR53","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.7150\/thno.81583","volume":"13","author":"L Deng","year":"2023","unstructured":"Deng L, Wojciech L, Png CW, Kioh DYQ, Gu Y, Aung TT, Malleret B, Chan ECY, Peng G, Zhang Y, et al. Colonization with two different Blastocystis subtypes in DSS-induced colitis mice is associated with strikingly different microbiome and pathological features. Theranostics. 2023;13:1165\u201379.","journal-title":"Theranostics"},{"key":"1441_CR54","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1007\/s00018-022-04271-9","volume":"79","author":"L Deng","year":"2022","unstructured":"Deng L, Wojciech L, Png CW, Koh EY, Aung TT, Kioh DYQ, Chan ECY, Malleret B, Zhang Y, Peng G, et al. Experimental colonization with Blastocystis ST4 is associated with protective immune responses and modulation of gut microbiome in a DSS-induced colitis mouse model. Cell Mol Life Sci. 2022;79:245.","journal-title":"Cell Mol Life Sci"},{"key":"1441_CR55","doi-asserted-by":"publisher","first-page":"2181","DOI":"10.1038\/s41396-022-01262-3","volume":"16","author":"J Mayneris-Perxachs","year":"2022","unstructured":"Mayneris-Perxachs J, Arnoriaga-Rodr\u00edguez M, Garre-Olmo J, Puig J, Ramos R, Trelis M, Burokas A, Coll C, Zapata-Tona C, Pedraza S, et al. Presence of Blastocystis in gut microbiota is associated with cognitive traits and decreased executive function. Isme J. 2022;16:2181\u201397.","journal-title":"Isme J"},{"key":"1441_CR56","first-page":"9","volume":"2020","author":"I Schoultz","year":"1909","unstructured":"Schoultz I, Keita \u00c5V. The intestinal barrier and current techniques for the assessment of gut permeability. Cells. 1909;2020:9.","journal-title":"Cells"},{"key":"1441_CR57","doi-asserted-by":"publisher","first-page":"11","DOI":"10.5217\/ir.2015.13.1.11","volume":"13","author":"SH Lee","year":"2015","unstructured":"Lee SH. Intestinal permeability regulation by tight junction: implication on inflammatory bowel diseases. Intestin Res. 2015;13:11.","journal-title":"Intestin Res"},{"key":"1441_CR58","doi-asserted-by":"publisher","first-page":"758","DOI":"10.3390\/toxins13110758","volume":"13","author":"MJ Kozie\u0142","year":"2021","unstructured":"Kozie\u0142 MJ, Ziaja M, Piastowska-Ciesielska AW. Intestinal barrier, claudins and mycotoxins. Toxins. 2021;13:758.","journal-title":"Toxins"},{"key":"1441_CR59","doi-asserted-by":"publisher","first-page":"712","DOI":"10.7150\/ijbs.45885","volume":"17","author":"X Zhao","year":"2021","unstructured":"Zhao X, Zeng H, Lei L, Tong X, Yang L, Yang Y, Li S, Zhou Y, Luo L, Huang J. Tight junctions and their regulation by non-coding RNAs. Int J Biol Sci. 2021;17:712.","journal-title":"Int J Biol Sci"},{"issue":"11","key":"1441_CR60","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2022.102461","volume":"298","author":"M Xi","year":"2022","unstructured":"Xi M, Zhao P, Li F, Bao H, Ding S, Ji L, Yan J. MicroRNA-16 inhibits the TLR4\/NF-\u03baB pathway and maintains tight junction integrity in irritable bowel syndrome with diarrhea. J Biol Chem. 2022;298(11): 102461.","journal-title":"J Biol Chem"}],"container-title":["European Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-023-01441-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40001-023-01441-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-023-01441-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,6]],"date-time":"2023-11-06T09:05:57Z","timestamp":1699261557000},"score":1,"resource":{"primary":{"URL":"https:\/\/eurjmedres.biomedcentral.com\/articles\/10.1186\/s40001-023-01441-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,6]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1441"],"URL":"https:\/\/doi.org\/10.1186\/s40001-023-01441-8","relation":{},"ISSN":["2047-783X"],"issn-type":[{"value":"2047-783X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,6]]},"assertion":[{"value":"11 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 November 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All experimental protocols were in accordance to the ethical principles and the national norms and standards for conducting Medical Research in Iran. This study was approved by the ethical standards (IR.IAU.SRB.REC.1400.241) released by Ethical Review Committees of Islamic Azad University- Science and Research Branch, Tehran, Iran.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors declare that they have seen and approved the submitted version of this manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"483"}}